Lv4
481 积分 2021-09-12 加入
Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application
2天前
已完结
Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application
9天前
已完结
Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS
15天前
已完结
A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS
15天前
已完结
Dispersive SPE, an alternative to traditional SPE for extraction of 43 doping peptides from equine urine prior to LC–MS screening
16天前
已完结
Development of a mass spectrometry based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes
16天前
已完结
Analysis and Characterization of Kisspeptin and Its Analogues in Serum and Urine Samples by Liquid Chromatography–High‐Resolution Mass Spectrometry for Doping Control Purposes
18天前
已完结
Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability
4个月前
已完结
Hair analysis to document ayahuasca consumption by LC-MS/MS
5个月前
已关闭
667-P: IBI362 (LY3305677), a Weekly-Dose Glucagon-Like Peptide-1/Glucagon Receptor Dual Agonist, in Subjects with Overweight or Obesity
5个月前
已关闭
皖公网安备34019202002308
